QA: XBiotech Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001626878_2023_XBiotech_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001626878, XBiotech Inc.

  xvar xval
0 AssetsCurrent 219,843,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 26,260,000
3 remainder_Assets 0
4 LiabilitiesCurrent 4,066,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 1,635,000
7 CostOfGoodsAndServicesSold 651,000
8 SellingGeneralAndAdministrativeExpense 6,305,000
9 ResearchAndDevelopmentExpense 31,544,000
10 remainder_Expenses -688,000
11 remainder_Revenues 4,010,000
12 remainder_NetIncome 902,000
13 remainder_ComprehensiveNetIncome -1,145,000
  yvar yval
0 Assets 246,103,000
1 Liabilities 5,701,000
2 Expenses 37,812,000
3 Revenues 4,010,000
4 StockholdersEquity 240,402,000
5 NetIncome -32,900,000
6 ComprehensiveNetIncome -33,472,500
7 BaseVar 147,836,500
8 EconomicCapitalRatio 3.02

Edgar->Model Mapping

Feature Distribution

Change over Time